Press release
Cardiac Resynchronization Therapy Market to Reach USD 6.51 Billion by 2031, Driven by Expanding Clinical Adoption and Shift Toward Value-Based Care
Cardiac Resynchronization Therapy Market Overview
The Cardiac resynchronization therapy market continues to show steady progress as healthcare systems focus on improving outcomes for patients with heart failure. According to industry analysis, the Cardiac resynchronization therapy market size was valued at USD 5.03 billion in 2025 and is estimated to grow from USD 5.25 billion in 2026 to reach USD 6.51 billion by 2031, registering a CAGR of 4.39% during the forecast period. This growth reflects consistent demand for device-based cardiac care and the growing importance of long-term disease management.
The Cardiac resynchronization therapy industry is shaped by the increasing burden of cardiovascular diseases and a broader shift toward therapies that reduce hospital readmissions. As healthcare providers move beyond procedure volume and focus more on patient outcomes, CRT devices are gaining importance as a reliable treatment option. The market is also benefiting from improvements in diagnostic tools that identify eligible patients earlier, supporting sustained demand across regions.
Access the complete data-driven outlook on the Cardiac resynchronization therapy Market now - https://www.mordorintelligence.com/industry-reports/cardiac-resynchronization-therapy-market?utm_source=abnewswire
Cardiac Resynchronization Therapy Market Trends
Rising Heart Failure Burden
One of the most important Cardiac resynchronization therapy market trends is the growing number of patients diagnosed with heart failure. With lifestyle changes, aging populations, and increasing cardiovascular risk factors, more patients require advanced device-based therapies. CRT devices help improve heart function and reduce hospitalizations, making them a preferred option in clinical practice.
Growing Aging Population
The expanding elderly population is another major factor influencing Cardiac resynchronization therapy market growth. Older adults are more likely to experience cardiac conditions that require rhythm management. This demographic trend is particularly strong in developing regions, where healthcare access is improving and treatment adoption is increasing.
Shift Toward Value-Based Care
Healthcare providers are focusing more on cost efficiency and long-term outcomes. CRT devices support this approach by reducing repeat hospital visits and improving patient quality of life. This shift is influencing purchasing decisions and shaping the overall Cardiac resynchronization therapy market forecast.
For a more tailored understanding, view the localized Japanese edition alongside the global market breakdown - https://www.mordorintelligence.com/ja/industry-reports/cardiac-resynchronization-therapy-market?utm_source=abnewswire
Cardiac Resynchronization Therapy Market Segmentation
*
By Device Type
*
CRT-Defibrillators
*
CRT-Pacemakers
*
By End User
*
Hospitals and Cardiac Centers
*
Ambulatory Surgical Centers
*
Other Healthcare Settings
*
By Application
*
Intraventricular Dyssynchrony
*
Interventricular Dyssynchrony
*
Atrioventricular Dyssynchrony
*
By Technology
*
Conventional Bi-Ventricular Pacing
*
His-Bundle Pacing
*
Left Bundle Branch Area Pacing
*
By Geography
*
North America
*
Europe
*
Asia-Pacific
*
Middle East and Africa
*
South America
Cardiac Resynchronization Therapy Market Key Players
*
Abbott Laboratories
*
Boston Scientific Corporation
*
Medtronic Plc
*
BIOTRONIK
*
Lepu Medical Technology (Beijing) Co., Ltd.
Conclusion
The Cardiac resynchronization therapy market is expected to maintain steady progress as healthcare systems continue to prioritize effective management of heart failure. With increasing awareness, better diagnostic capabilities, and supportive healthcare policies, the adoption of CRT devices is likely to expand further.
Overall, the Cardiac resynchronization therapy market forecast remains positive, supported by consistent demand, ongoing improvements in treatment approaches, and expanding access to advanced cardiac care across both developed and emerging regions.
Industry Related Reports:
Canada Cardiovascular Devices Market
The Canada cardiovascular devices market is estimated at USD 1.81 billion in 2026, growing from USD 1.7 billion in 2025 and projected to reach USD 2.44 billion by 2031 at a CAGR of 6.18%. Growth is supported by rising cardiovascular disease prevalence, increasing adoption of minimally invasive procedures, and strong healthcare infrastructure with favorable reimbursement policies.
https://www.mordorintelligence.com/industry-reports/canada-cardiovascular-devices-market?utm_source=abnewswire
Cardiovascular and Soft Tissue Repair Patches Market
The cardiovascular and soft tissue repair patches market is expected to grow from USD 5.13 billion in 2025 to USD 5.55 billion in 2026, reaching USD 8.23 billion by 2031 at a CAGR of 8.18%. Expansion is driven by growing surgical procedures, increasing demand for biologic and synthetic patches, and advancements in tissue repair technologies.
https://www.mordorintelligence.com/industry-reports/cardiovascular-and-soft-tissue-repair-patches-market?utm_source=abnewswire
Europe Cardiac Assist Devices Market
The Europe cardiac assist devices market is projected to grow at a CAGR of 7.6% during the forecast period. Growth is influenced by the rising burden of heart failure, increasing adoption of ventricular assist devices, and supportive regulatory frameworks across European healthcare systems.
https://www.mordorintelligence.com/industry-reports/europe-cardiac-assist-devices-market-industry?utm_source=abnewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cardiac-resynchronization-therapy-market-to-reach-usd-651-billion-by-2031-driven-by-expanding-clinical-adoption-and-shift-toward-valuebased-care]
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiac Resynchronization Therapy Market to Reach USD 6.51 Billion by 2031, Driven by Expanding Clinical Adoption and Shift Toward Value-Based Care here
News-ID: 4491533 • Views: …
More Releases from ABNewswire
Benign Prostatic Hyperplasia Market to Reach USD 10.61 Billion by 2031, Driven b …
Explore the Benign prostatic hyperplasia market (2026-2031) with Mordor Intelligence. Get in-depth insights on market size, share, revenue, segments, key drivers, latest trends, and growth opportunities shaping the future of sustainable construction.
Benign Prostatic Hyperplasia Market Overview and Introduction
The Benign prostatic hyperplasia market continues to show steady expansion, supported by demographic trends and evolving treatment approaches. According to recent analysis, the Benign prostatic hyperplasia market size is expected to grow from…
Optical Coatings Market Advances Steadily to 237 Million Square Meters by 2033, …
From photovoltaic panels to precision aerospace optics, optical coatings are quietly powering some of the most critical technological transitions of this decade.
The Global Optical Coatings Industry is expanding at a measured but structurally well-supported pace. The Optical Coatings Market recorded a sales demand of 206 million square meters in 2025 and is estimated to reach 237 million square meters by 2033, growing at a CAGR of 2.3% during the forecast…
Edge Data Center Market to Nearly Triple in Value by 2033, Powered by AI Workloa …
As hyperscalers push infrastructure closer to end users and enterprises embrace hybrid cloud strategies, edge data centers are emerging as the critical backbone of next-generation digital ecosystems.
The Global Edge Data Center Industry is entering a period of accelerated, large-scale expansion. The Edge Data Center Market recorded a value of USD 27,300 million in 2025 and is estimated to reach USD 72,656 million by 2033, growing at a CAGR of 14%…
Best Flea & Tick Collar for Dogs in 2026 - Bestdogfleacollars.best Ranks DEWEL # …
A 2026 review by Bestdogfleacollars.best ranks DEWEL as the best flea and tick collar for dogs, highlighting the growing demand for long-lasting, easy-to-use protection.
As flea and tick season expands across the United States in 2026, dog owners are placing greater emphasis on finding reliable, long-lasting protection that fits seamlessly into their routine. With a wide range of products available-from topical treatments to oral medications and collars-the decision-making process has become…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
